Canadians rally for national standards for breast ca testing
After it was reported that 25 labs in Quebec incorrectly identified markers for hormone therapy in 15% to 20% of breast cancer patients, the Canadian Breast Cancer Network called for urgent action to implement systemic changes in national standards for breast cancer testing.
After it was reported that 25 labs in Quebec incorrectly identified markers for hormone therapy in 15% to 20% of breast cancer patients, the Canadian Breast Cancer Network called for urgent action to implement systemic changes in national standards for breast cancer testing.
CBCN President Diana Ermel said uniform standards are a necessary first step to begin restoring confidence in the Canadian medical system. CBCN also recommends the inclusion of breast cancer survivors on all national committees and commissions to help set testing standards.
